430 related articles for article (PubMed ID: 25994664)
1. The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study.
Cameron ST; Berger C; Michie L; Klipping C; Gemzell-Danielsson K
Hum Reprod; 2015 Jul; 30(7):1566-72. PubMed ID: 25994664
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception.
Brache V; Cochon L; Duijkers IJ; Levy DP; Kapp N; Monteil C; Abitbol JL; Klipping C
Hum Reprod; 2015 Dec; 30(12):2785-93. PubMed ID: 26405263
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ulipristal acetate for emergency contraception and its effect on the subsequent bleeding pattern when administered before or after ovulation.
Li HW; Lo SS; Ng EH; Ho PC
Hum Reprod; 2016 Jun; 31(6):1200-7. PubMed ID: 27052501
[TBL] [Abstract][Full Text] [Related]
4. Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study.
Edelman AB; Jensen JT; McCrimmon S; Messerle-Forbes M; O'Donnell A; Hennebold JD
Contraception; 2018 Dec; 98(6):463-466. PubMed ID: 30118684
[TBL] [Abstract][Full Text] [Related]
5. The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg.
Banh C; Rautenberg T; Duijkers I; Borenzstein P; Monteil C; Levy-Gompel D; Klipping C; Scherrer B; Glasier A
Contraception; 2020 Sep; 102(3):145-151. PubMed ID: 32474062
[TBL] [Abstract][Full Text] [Related]
6. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture.
Brache V; Cochon L; Jesam C; Maldonado R; Salvatierra AM; Levy DP; Gainer E; Croxatto HB
Hum Reprod; 2010 Sep; 25(9):2256-63. PubMed ID: 20634186
[TBL] [Abstract][Full Text] [Related]
7. A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate.
Jesam C; Cochon L; Salvatierra AM; Williams A; Kapp N; Levy-Gompel D; Brache V
Contraception; 2016 Apr; 93(4):310-316. PubMed ID: 26764121
[TBL] [Abstract][Full Text] [Related]
8. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.
Brache V; Cochon L; Deniaud M; Croxatto HB
Contraception; 2013 Nov; 88(5):611-8. PubMed ID: 23809278
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects of ulipristal acetate on fertilization and early embryo development in mice.
Gómez-Elías MD; Munuce MJ; Bahamondes L; Cuasnicú PS; Cohen DJ
Hum Reprod; 2016 Jan; 31(1):53-9. PubMed ID: 26582845
[TBL] [Abstract][Full Text] [Related]
10. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
11. Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system.
Berger C; Boggavarapu NR; Menezes J; Lalitkumar PG; Gemzell-Danielsson K
Hum Reprod; 2015 Apr; 30(4):800-11. PubMed ID: 25740886
[TBL] [Abstract][Full Text] [Related]
12. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.
Glasier AF; Cameron ST; Fine PM; Logan SJ; Casale W; Van Horn J; Sogor L; Blithe DL; Scherrer B; Mathe H; Jaspart A; Ulmann A; Gainer E
Lancet; 2010 Feb; 375(9714):555-62. PubMed ID: 20116841
[TBL] [Abstract][Full Text] [Related]
13. A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception.
Huang Y; Jensen JT; Brache V; Cochon L; Williams A; Miranda MJ; Croxatto H; Kumar N; Sussman H; Hoskin E; Plagianos M; Roberts K; Merkatz R; Blithe D; Sitruk-Ware R
Contraception; 2014 Dec; 90(6):565-74. PubMed ID: 25193534
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women.
Schütt B; Kaiser A; Schultze-Mosgau MH; Seitz C; Bell D; Koch M; Rohde B
Hum Reprod; 2016 Aug; 31(8):1703-12. PubMed ID: 27288475
[TBL] [Abstract][Full Text] [Related]
15. A prostaglandin E2 receptor antagonist prevents pregnancies during a preclinical contraceptive trial with female macaques.
Peluffo MC; Stanley J; Braeuer N; Rotgeri A; Fritzemeier KH; Fuhrmann U; Buchmann B; Adevai T; Murphy MJ; Zelinski MB; Lindenthal B; Hennebold JD; Stouffer RL
Hum Reprod; 2014 Jul; 29(7):1400-12. PubMed ID: 24781425
[TBL] [Abstract][Full Text] [Related]
16. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium.
Whitaker LH; Murray AA; Matthews R; Shaw G; Williams AR; Saunders PT; Critchley HO
Hum Reprod; 2017 Mar; 32(3):531-543. PubMed ID: 28130434
[TBL] [Abstract][Full Text] [Related]
17. Effect of ulipristal acetate and mifepristone at emergency contraception dose on the embryo-endometrial attachment using an in vitro human trophoblastic spheroid and endometrial cell co-culture model.
Li HWR; Li YX; Li TT; Fan H; Ng EH; Yeung WS; Ho PC; Lee KF
Hum Reprod; 2017 Dec; 32(12):2414-2422. PubMed ID: 29121217
[TBL] [Abstract][Full Text] [Related]
18. Model for Hormonal Emergency Contraception (HEC) in cycling and mated guinea pigs - Studies with the Progesterone Receptor Modulators (PRM) Ulipristal Acetate (UPA/CDB2914) and EC317.
Elger W; Schneider B; Killeen Z; Jewgenow K; Dehnhard M; Friedrich M; Santhamma B; Wedemeyer R; Nickisch K
J Steroid Biochem Mol Biol; 2018 Oct; 183():152-158. PubMed ID: 29902513
[TBL] [Abstract][Full Text] [Related]
19. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
20. A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.
Festin MP; Bahamondes L; Nguyen TM; Habib N; Thamkhantho M; Singh K; Gosavi A; Bartfai G; Bito T; Bahamondes MV; Kapp N
Hum Reprod; 2016 Mar; 31(3):530-40. PubMed ID: 26830816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
